05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:08 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
8:30 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
8:20 AM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
04/24/2024
5:23 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/24/2024
5:25 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/23/2024
11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
04/03/2024
4:27 PM | Aquestive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/01/2024
5:21 PM | Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
04/01/2024
7:15 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
1:30 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:56 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:45 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:34 AM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:09 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:12 PM | Aquestive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:24 PM | Aquestive Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
12/08/2023
9:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
7:51 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
4:04 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
4:20 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
4:22 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
7:45 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
11:04 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2023
11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
Look Who Fired the World’s Richest Man (Ad) This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S.
And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman. Get the full story here. |
09/20/2023
3:39 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
12:14 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
4:22 PM | Aquestive Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023
7:22 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
8:23 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
8:05 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
12:41 PM | Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
11:26 AM | Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
11:26 AM | Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
11:27 AM | Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
11:28 AM | Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
11:24 AM | Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
8:54 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
8:06 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
